Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells

Life Sciences

Volumn 153, Issue , 2016, Pages 41-49

  Buranrat, Benjaporn ^a   Senggunprai, Laddawan ^b,c   Prawan, Auemduan ^b,c   Kukongviriyapan, Veerapol ^b,c  

^a MAHASARAKHAM UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Apoptosis; Atorvastatin; Cell death; Cholangiocarcinoma; Simvastatin

Indexed keywords

ATORVASTATIN; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER INHIBITION; CELL MIGRATION; CHOLANGIOCARCINOMA CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; IC50; KKU 100 CELL LINE; KKU M055 CELL LINE; KKU M156 CELL LINE; KKU M214 CELL LINE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BILE DUCT TUMOR; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; ATORVASTATIN CALCIUM; BILE DUCT NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; REACTIVE OXYGEN SPECIES; SIMVASTATIN;

EID: 84964582964     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.04.018     Document Type: Article

References (31)

1. J.L. Goldstein, and M.S. Brown Regulation of the mevalonate pathway Nature 343 6257 1990 425 430
2. W.W. Wong, J. Dimitroulakos, M.D. Minden, and L.Z. Penn HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 4 2002 508 519
3. A.B. Jaffe, and A. Hall Rho GTPases: biochemistry and biology Annu. Rev. Cell Dev. Biol. 21 2005 247 269
4. K. Hindler, C.S. Cleeland, E. Rivera, and C.D. Collard The role of statins in cancer therapy Oncologist 11 3 2006 306 315
5. S. Kotamraju, C.L. Williams, and B. Kalyanaraman Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways Cancer Res. 67 15 2007 7386 7394
6. C.A. Sanchez, E. Rodriguez, E. Varela, E. Zapata, A. Paez, F.A. Masso, and et al. Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress Cancer Investig. 26 7 2008 698 707
7. K.S. Ahn, G. Sethi, and B.B. Aggarwal Simvastatin potentiates TNF-alpha-induced apoptosis through the down-regulation of NF-kappaB-dependent antiapoptotic gene products: role of IkappaBalpha kinase and TGF-beta-activated kinase-1 J. Immunol. 178 4 2007 2507 2516
8. K.E. Hwang, K.S. Na, D.S. Park, K.H. Choi, B.R. Kim, H. Shim, and et al. Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin Investig. New Drugs 29 5 2011 945 952
9. C. Spampanato, S. De Maria, M. Sarnataro, E. Giordano, M. Zanfardino, S. Baiano, and et al. Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression Int. J. Oncol. 40 4 2012 935 941
10. M. Kamigaki, T. Sasaki, M. Serikawa, M. Inoue, K. Kobayashi, H. Itsuki, and et al. Statins induce apoptosis and inhibit proliferation in cholangiocarcinoma cells Int. J. Oncol. 39 3 2011 561 568
11. T. Kusama, M. Mukai, T. Iwasaki, M. Tatsuta, Y. Matsumoto, H. Akedo, and et al. 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis Gastroenterology 122 2 2002 308 317
12. B. Blechacz, and G.J. Gores Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 1 2008 308 321
13. S.A. Khan, S.D. Taylor-Robinson, M.B. Toledano, A. Beck, P. Elliott, and H.C. Thomas Changing international trends in mortality rates for liver, biliary and pancreatic tumours J. Hepatol. 37 6 2002 806 813
14. B. Sripa, J.M. Bethony, P. Sithithaworn, S. Kaewkes, E. Mairiang, A. Loukas, and et al. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos Acta Trop. 120 Suppl. 1 2011 S158 S168
15. J. Bridgewater, P.R. Galle, S.A. Khan, J.M. Llovet, J.W. Park, T. Patel, and et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma J. Hepatol. 60 6 2014 1268 1289
16. O. Farges, D. Fuks, E. Boleslawski, Y.P. Le Treut, D. Castaing, A. Laurent, and et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group Ann. Surg. 254 5 2011 824 829 (discussion 30)
17. J. Valle, H. Wasan, D.H. Palmer, D. Cunningham, A. Anthoney, and A. Maraveyas Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med. 362 14 2010 1273 1281
18. B. Buranrat, A. Prawan, U. Kukongviriyapan, S. Kongpetch, and V. Kukongviriyapan Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells World J. Gastroenterol. 16 19 2010 2362 2370
19. S. Kongpetch, V. Kukongviriyapan, A. Prawan, L. Senggunprai, U. Kukongviriyapan, and B. Buranrat Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents PLoS One 7 4 2012 e34994
20. P. Samatiwat, A. Prawan, L. Senggunprai, and V. Kukongviriyapan Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells Naunyn Schmiedeberg's Arch. Pharmacol. 388 6 2015 601 612
21. P. Zeekpudsa, V. Kukongviriyapan, L. Senggunprai, B. Sripa, and A. Prawan Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents J. Exp. Clin. Cancer Res. 33 2014 11
22. L. Senggunprai, V. Kukongviriyapan, A. Prawan, and U. Kukongviriyapan Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway Phytother. Res. 28 6 2014 841 848
23. B. Suphim, A. Prawan, U. Kukongviriyapan, S. Kongpetch, B. Buranrat, and V. Kukongviriyapan Redox modulation and human bile duct cancer inhibition by curcumin Food Chem. Toxicol. 48 8-9 2010 2265 2272
24. M. Parri, and P. Chiarugi Rac and Rho GTPases in cancer cell motility control. Cell Commun. Signal. 8 2010 23
25. A. Jusakul, S. Kongpetch, and B.T. Teh Genetics of Opisthorchis viverrini-related cholangiocarcinoma Curr. Opin. Gastroenterol. 31 3 2015 258 263
26. M.R. Soma, A. Corsini, and R. Paoletti Cholesterol and mevalonic acid modulation in cell metabolism and multiplication Toxicol. Lett. 64-65 1992 1 15 (Spec No)
27. C. Ukomadu, and A. Dutta p21-Dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases J. Biol. Chem. 278 44 2003 43586 43594
28. T. Miller, F. Yang, C.E. Wise, F. Meng, S. Priester, M.K. Munshi, and et al. Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity Dig. Liver Dis. 43 5 2011 395 403
29. S. Liu, H. Uppal, M. Demaria, P.Y. Desprez, J. Campisi, and P. Kapahi Simvastatin suppresses breast cancer cell proliferation induced by senescent cells Sci. Rep. 5 2015 17895
30. X.F. Qi, L. Zheng, K.J. Lee, D.H. Kim, C.S. Kim, D.Q. Cai, and et al. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway Cell Death Dis. 4 2013 e518
31. O. Tusskorn, L. Senggunprai, A. Prawan, U. Kukongviriyapan, and V. Kukongviriyapan Phenethyl isothiocyanate induces calcium mobilization and mitochondrial cell death pathway in cholangiocarcinoma KKU-M214 cells BMC Cancer 13 2014 571